Use of the ornithine transcarbamylase (OTC), as a marker for diagnosing brain damages

Details for Australian Patent Application No. 2007237839 (hide)

Owner Institut National De La Sante Et De La Recherche Medicale (INSERM) Genoscreen

Inventors Lambert, Jean-Charles; Ferreira, Stephanie; Amouyel, Philippe

Agent Fisher Adams Kelly

Pub. Number AU-A-2007237839

PCT Pub. Number WO2007/119179

Priority 06290619.3 18.04.06 EP

Filing date 18 April 2007

Wipo publication date 25 October 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/119179 Priority application(s): WO2007/119179

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007237840-Survival and development of neural cells

2007237837-Modified release formulations and methods of treating inflammatory bowel disease